SynthesisThe oncologist2022

Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysis.

Aparna R Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.